NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant model
Hampartsoum B. Barsoumian(The University of Texas MD Anderson Cancer Center), James W. Welsh(The University of Texas MD Anderson Cancer Center)
Cited by 17
Related Papers
The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells
|Radiation Oncology|2009|114
Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunity
|Journal for ImmunoTherapy of Cancer|2020|93
Bone morphogenetic protein 7 promotes resistance to immunotherapy
|Nature Communications|2020|58
Low-Dose Radiation Decreases Cancer-Associated Fibroblasts and May Increase T-Cell Trafficking into Tumors
|International Journal of Radiation Oncology*Biology*Physics|2020|7